Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07004192 · ClinicalTrials.gov registry record · Phase 4

The Role of hCG in Thawed Embryo Transfer

A Phase 4 study of Infertility (IVF Patients), sponsored by Fertility Center of Las Vegas.

Recruiting
Registry status
Phase 4
Development phase
220
Enrollment target
1
Study location

NCT07004192: Recruiting Phase 4 study of Infertility (IVF Patients), sponsored by Fertility Center of Las Vegas.

NCT07004192 is a Phase 4 study of Infertility (IVF Patients) that is actively recruiting participants, run by Fertility Center of Las Vegas. The registered enrollment target is 220 participants, below the 455-participant average among 9 other Infertility (IVF Patients) trials with a reported enrollment target (52% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07004192, a Phase 4 study of Infertility (IVF Patients), is actively recruiting participants, sponsored by Fertility Center of Las Vegas.

RECRUITING
Registry status
Phase 4
Development phase
220 participants
Enrollment target
1
Study location

Study Summary

This prospective randomized trial will assess the relevance, if any, of a corpus luteum induced by hCG in transfers of thawed embryos.

Primary Outcome

Mean arterial pressure measured in third trimester of pregnancy

Conditions Studied

Interventions

  • OTHER No intervention
  • DRUG HCG injection

Study Locations (1)

Nevada

  • Fertility Center of Las Vegas - Las Vegas

Trial Details

FieldValue
Enrollment Target 220 participants
Start Date 2025-06-02
Est. Completion 2027-12-31
Phase Phase 4
Fertility Center of Las Vegas

4 total trials

What NCT07004192 shows while recruiting

NCT07004192 is an interventional study that assigns participants to a tested intervention. The registered 220 participants enrollment target is mid-sized for trials with a published cap, below the 455-participant average among 9 other Infertility (IVF Patients) trials with a reported enrollment target (52% lower).

The record links to 1 condition, with Infertility (IVF Patients) appearing as the primary indexed condition, and to 2 interventions - of which No intervention is the first listed.

NCT07004192 reports a single indexed study location in Nevada.

Frequently Asked Questions

What is clinical trial NCT07004192 about?

NCT07004192 is a clinical study titled "The Role of hCG in Thawed Embryo Transfer". This prospective randomized trial will assess the relevance, if any, of a corpus luteum induced by hCG in transfers of thawed embryos.

What is the current status of trial NCT07004192?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 220 participants. The study started on 2025-06-02. Estimated completion is 2027-12-31.

What conditions does trial NCT07004192 study?

This clinical trial studies the following conditions: Infertility (IVF Patients).

What interventions are being tested in trial NCT07004192?

The interventions under investigation include: No intervention (OTHER), HCG injection (DRUG).

Who is sponsoring clinical trial NCT07004192?

This trial is sponsored by Fertility Center of Las Vegas, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07004192 being conducted?

This trial has 1 study location across Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Infertility (IVF Patients)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07004192's enrollment target sits among peer trials

220 5th of 9 higher than 5 of 9 other Infertility (IVF Patients) trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Infertility (IVF Patients) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00920972 · 220 participants · Phase 1

    Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases

  • NCT01851642 · 220 participants

    Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs

  • NCT02582021 · 220 participants

    WISE CVD - Continuation (WISE HFpEF)

  • NCT04067830 · 220 participants · Phase 2

    Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07004192, the US trial registry maintained by the National Library of Medicine. NCT07004192 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.